If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDe La Rue Regulatory News (DLAR)

  • This share is currently suspended. It was suspended at a price of 130.00
  • There is currently no data for DLAR

Director/PDMR Shareholding

9 Jul 2024 16:22

RNS Number : 7412V
De La Rue PLC
09 July 2024
 

De La Rue plc

 

Director/PDMR Shareholding

Notification of transactions by persons discharging managerial responsibilities and persons closely associated with them

9 July 2024

De La Rue plc (the "Company") announces that on 8 July 2024 awards made under the De La Rue Deferred Bonus Plan (the "DBP") to Clive Vacher and Ruth Euling (each of whom is an Executive Director and a Person Discharging Managerial Responsibilities ("PDMR") of the Company) automatically vested and were released.

In line with the rules of the DBP, the Company withheld a proportion of each award and sold sufficient Shares to fund income tax and national insurance withholdings and the associated dealing costs. These Shares were sold in the market on 8 July 2024 at a weighted average price of 97.789 pence per Share.

The awards which automatically vested were granted under the DBP on 6 July 2022 (the shares released being the second half of the portion of the FY22 bonus which was deferred and share settled).

The vesting of these awards and the sale of shares to fund withholdings creates a change in the interests of each of them in the ordinary shares of 44152/175p of the Company ("Shares"):

Name of Director/PDMR

Role

Number of Shares subject to the Awards vesting

Number of Shares sold in the market

Number of Shares retained by the PDMR

Clive Vacher

CEO

67,315

31,751

35,564

Ruth Euling

MD, Currency

31,844

15,021

16,823

 

Following these transactions, the holdings of each of the PDMRs of the Company's Shares are as follows:

 

Name of Director/PDMR

Role

Number of Shares held by the PDMR

Clive Vacher

CEO

338,687

Ruth Euling

MD, Currency

102,225

 

 

 

The relevant information set out below is provided in accordance with the requirements of Article 19 of the Market Abuse Regulation as retained in UK law.

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Clive Vacher

2

 

Reason for the notification

 

a)

 

Position/status

 

Executive Director/Chief Executive Officer

b)

 

Initial notification /Amendment

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

De La Rue plc

b)

 

LEI

 

213800DH741LZWIJXP78

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary shares of 44152/175p

 

 

GB00B3DGH821

b)

 

Nature of the transaction

 

 

(a) Vesting of a conditional award in respect of a total of 67,315 Shares under the rules of the De La Rue Deferred Bonus Plan.

(b) Sale of Shares to fund income tax and national insurance withholdings and the associated dealing costs

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

 

(a) £0.00

(b) £0.97789

 

(a) 67,315

(b) 31,751

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

- Aggregated total

N/A

 

 

 

 

 

 

 

e)

 

Date of the transaction

 

(a) 8 July 2024

(b) 8 July 2024

f)

 

Place of the transaction

 

(a) Outside a trading venue

(b) London Stock Exchange

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Ruth Euling

2

 

Reason for the notification

 

a)

 

Position/status

 

Executive Director/MD, Currency

b)

 

Initial notification /Amendment

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

De La Rue plc

b)

 

LEI

 

213800DH741LZWIJXP78

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

Ordinary shares of 44152/175p

 

 

GB00B3DGH821

b)

 

Nature of the transaction

 

 

(a) Vesting of a conditional award in respect of a total of 31,844 Shares under the rules of the De La Rue Deferred Bonus Plan.

(b) Sale of Shares to fund income tax and national insurance withholdings and the associated dealing costs

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

 

(a) £0.00

(b) £0.97789

 

(a) 31,844

(b) 15,021

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

- Aggregated total

N/A

 

 

 

 

 

 

 

e)

 

Date of the transaction

 

(a) 8 July 2024

(b) 8 July 2024

f)

 

Place of the transaction

 

(a) Outside a trading venue

(b) London Stock Exchange

 

 

Jon Messent, Company Secretary

Contact Number: 01256 605212

9 July 2024

 

De La Rue plc's LEI code is 213800DH741LZWIJXP78.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEASXNEAFLEFA
Date   Source Headline
8th Jul 20212:43 pmRNSDirector/PDMR Shareholding
6th Jul 20212:51 pmRNSDirector/PDMR Shareholding
1st Jul 20214:35 pmRNSBlock listing Interim Review
1st Jul 20214:21 pmRNSTotal Voting Rights
1st Jul 20218:00 amRNSDirector/PDMR Shareholding
28th Jun 20213:55 pmRNSHolding(s) in Company
24th Jun 202111:24 amRNSHolding(s) in Company
18th Jun 20211:44 pmRNSAnnual Financial Report
1st Jun 202111:23 amRNSTotal Voting Rights
26th May 20217:00 amRNS2020/21 Full Year Results
13th May 20217:00 amRNSAUTHENTICATION CONTRACT WINS
4th May 20212:07 pmRNSTotal Voting Rights
13th Apr 20217:00 amRNSTrading Statement
1st Apr 20217:00 amRNSTotal Voting Rights
23rd Mar 20215:09 pmRNSHolding(s) in Company
23rd Mar 20217:00 amRNSDirectorate Change
1st Mar 202112:20 pmRNSTotal Voting Rights
1st Feb 202112:37 pmRNSTotal Voting Rights
28th Jan 202112:59 pmRNSHolding(s) in Company
28th Jan 20217:00 amRNSTrading Statement
5th Jan 20219:36 amRNSDirector/PDMR Shareholding
4th Jan 202111:15 amRNSBlock listing Interim Review
4th Jan 202111:12 amRNSTotal Voting Rights
23rd Dec 202012:10 pmRNSDirector/PDMR Shareholding
1st Dec 20202:25 pmRNSTotal Voting Rights
1st Dec 20209:10 amRNSDirector/PDMR Shareholding
25th Nov 20207:00 amRNS2020/21 HALF YEAR RESULTS
4th Nov 20201:45 pmRNSHolding(s) in Company
30th Oct 20207:00 amRNSEXTENSION OF THE BANK OF ENGLAND CONTRACT
21st Oct 202011:32 amRNSHolding(s) in Company
15th Oct 20207:00 amRNSTrading Update
1st Oct 20201:30 pmRNSTotal Voting Rights
1st Oct 20207:00 amRNSChief Financial Officer Appointment
22nd Sep 20207:00 amRNSDirectorate Change
1st Sep 202012:14 pmRNSTotal Voting Rights
24th Aug 20203:05 pmRNSHolding(s) in Company
13th Aug 20207:00 amRNSAppointment of Joint Broker
7th Aug 20204:42 pmRNSHolding(s) in Company
6th Aug 202012:40 pmRNSResult of AGM
6th Aug 20207:00 amRNSAGM Statement
4th Aug 20209:37 amRNSHolding(s) in Company
31st Jul 20203:52 pmRNSTotal Voting Rights
27th Jul 20207:00 amRNSAdditional Listing
22nd Jul 20206:00 pmRNSHolding(s) in Company
16th Jul 20205:12 pmRNSDirector/PDMR Shareholding
15th Jul 20204:13 pmRNSHolding(s) in Company
14th Jul 20203:03 pmRNSHolding(s) in Company
14th Jul 20202:40 pmRNSHolding(s) in Company
13th Jul 20203:18 pmRNSNotice of AGM
13th Jul 20203:13 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.